Reversibility of vulvar atypia by DNCB-induced delayed hypersensitivity.
D000328:Adult; D001706:Biopsy; D002278:Carcinoma in Situ / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology; D002713:Chlorine; D005260:Female; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced*; D007167:Immunotherapy; D008875:Middle Aged; D009578:Nitrobenzenes / Q000008:administration & dosage; D012867:Skin / Q000276:immunology; D014844:Vulva / Q000473:pathology; D014846:Vulvar Neoplasms / Q000188:drug therapy / Q000276:immunology* / Q000473:pathology
D009578:Nitrobenzenes; D002713:Chlorine; D005472:Fluorouracil